Cerebrotendinous Xanthomatosis

Guidance. Research. Community. 

The FDA has approved a Patient-Focused Drug Development meeting about CTX on September 14, 2021 hosted by the United Leukodystrophy Foundation.

pexels-pixabay-355948

News